Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65630 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Sunitinib N-Oxide ((Z)-N,N-diethyl-2-(5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamido)ethan-1-amine oxide)
CAS :Lactams, nesoiFormule :C22H27FN4O3Couleur et forme :Yellow Orange SolidMasse moléculaire :414.20672Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS :Sulfonamides, nesoiFormule :C19H27N3O6S2Couleur et forme :Off-White PowderMasse moléculaire :457.13413Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C17H23N3OCouleur et forme :Off-White PowderMasse moléculaire :285.18411Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H27N3O3Couleur et forme :White Fine PowderMasse moléculaire :333.20524Bupropion Amine Tosylate (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C16H18ClNO4SCouleur et forme :White SolidMasse moléculaire :355.064512-Vinylpyridine (2-Ethenylpyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H7NCouleur et forme :Light Brown LiquidMasse moléculaire :105.05785Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS :Sulfonamides, nesoiFormule :C23H31N7O7SCouleur et forme :White PowderMasse moléculaire :549.20057Leflunomide Related Compound C (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :Yellow White PowderMasse moléculaire :270.061615-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H6O3Couleur et forme :Yellow SolidMasse moléculaire :126.03169Oxcarbazepine Related Compound B (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H14N2O3Couleur et forme :White Yellow PowderMasse moléculaire :294.10044Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H41N7O5Couleur et forme :PowderMasse moléculaire :627.31692Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5Cl2NOCouleur et forme :White Off-White PowderMasse moléculaire :212.97482Clozapine Resolution Mixture
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :Yellow Crystalline PowderMasse moléculaire :203.09061Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C23H33NO4Couleur et forme :White Off-White SolidMasse moléculaire :387.24096Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.08202Plerixafor
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C28H54N8Couleur et forme :White Off-White PowderMasse moléculaire :502.44714Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C11H11F2N3O2Couleur et forme :White SolidMasse moléculaire :255.08193Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C36H36N6O10Couleur et forme :Off-White SolidMasse moléculaire :712.24929Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C9H7NO2Couleur et forme :White Off-White SolidMasse moléculaire :161.04768Sorbitol
CAS :D-glucitol (sorbitol)Formule :C6H14O6Couleur et forme :White Crystalline PowderMasse moléculaire :182.17 g/molSalmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderAmbrisentan R-Enantiomer ((R)-2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C22H22N2O4Couleur et forme :White Fine PowderMasse moléculaire :378.15796Deoxybicalutamide (N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenylsulfonyl)-2-methylpropanamide)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O3SCouleur et forme :SolidMasse moléculaire :414.06613Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :White Off-White SolidMasse moléculaire :195.91526Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White PowderMasse moléculaire :275.084373-Acetamidophthalic acid (3-acetamidophthalic acid)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H9NO5Couleur et forme :Off-White SolidMasse moléculaire :223.04807Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H42N4O5Couleur et forme :Off-White SolidMasse moléculaire :562.31552Naproxen Related Compound A (6-methoxy-2-naphthoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C12H10O3Couleur et forme :White Off-White PowderMasse moléculaire :202.06299Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSHClCouleur et forme :White Off-White PowderMasse moléculaire :315.16569Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C14H23N3O2Couleur et forme :White Off-White PowderMasse moléculaire :265.17903Methyl Acetate
CAS :Esters of acetic acid not elsewhere specified or includFormule :C3H6O2Couleur et forme :Colorless Clear LiquidMasse moléculaire :74.08 g/molLabetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H23NO4·HClCouleur et forme :Off-White SolidMasse moléculaire :365.13939Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H13N3O3Couleur et forme :Off-White SolidMasse moléculaire :271.09569Labetalol Related Compound F (2-Hydroxy-5-[(4-phenylbutan-2-yl)glycyl]benzamide hydrochloride)
CAS :<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Formule :C19H22N2O3·HClCouleur et forme :White Off-White PowderMasse moléculaire :362.13972Duloxetine Related Compound F ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :Off-White PowderMasse moléculaire :333.09541Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :524.18265Glycerin
CAS :GlycerolFormule :C3H8O3Couleur et forme :Colorless Clear LiquidMasse moléculaire :92.04734Rivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O5Couleur et forme :White Off-White SolidMasse moléculaire :333.13247Saxagliptin
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C18H25N3O2·H2OCouleur et forme :White Off-White Light Brown Crystalline PowderMasse moléculaire :333.20524Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Ondansetron Hydrochloride
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C13H18O5Couleur et forme :White SolidMasse moléculaire :254.11542Rivaroxaban Desmorpholinone Analog ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18ClN3O4SCouleur et forme :White Off-White SolidMasse moléculaire :395.07065Fesoterodine Chloromandelate
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C26H37NO3·C8H7ClO3Couleur et forme :White Fine PowderMasse moléculaire :411.27734Desmethoxyomeprazole
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H17N3O2SCouleur et forme :Light Brown Grey Yellow PowderMasse moléculaire :315.10415Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H9NO2Couleur et forme :Dark Orange SolidMasse moléculaire :223.23
